ULTIMA GENOMICS, INC: public contracts won without a rival in United States

Updated 17 October 2026 · 2025-05-07 to 2025-08-29 · all of United States · record in the register

ULTIMA GENOMICS, INC: public contracts won without a rival in United States: 2 uncontested awards; 100% of its awards; 1 without a competition; 1 single bid.

Assay record ASY-US-0QIJB2Q1LV · Cite as: Assay Systems, “ULTIMA GENOMICS, INC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/ultima-genomics-inc/

1
2uncontested awards
100%of its awards
1without a competition
1single bid

ULTIMA GENOMICS, INC won 2 of its 2 public contract awards in United States without a rival from 2025-05-07 to 2025-08-29, worth $166K: 1 without a competition and 1 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest National Institutes of Health with 2.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

National Institutes of Health2uncontested2awards$166Kvalue

National Institutes of Health gave ULTIMA GENOMICS, INC 2 awards: 1 without a competition, 1 after a competition with a single bid. First 2025-05-07, latest 2025-08-29.

Latest awards without a rival

DateBuyerHowValueStated reason
2025-08-29National Institutes of Health
75N92025P00333
Single bid
COMPETED UNDER SAP
$146K—
2025-05-07National Institutes of Health
75N92E25P00158
No competition
NOT COMPETED
$19.9KONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)

Every uncontested award in United States · All countries · ULTIMA GENOMICS, INC in the register

Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.